Trial
NCT04200651
Prospective Study on DEXTENZA® Safety And Efficacy Following Concomitant MIGS and Cataract Surgery
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
The New York Eye Surgery Center
Collaborators
Ocular Therapeutix, Inc.
Condition
Glaucoma
Intervention
Dexamethasone Ophthalmic Insert
Why stopped
COVID-19 challenges to recruitment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-01-31